In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
D000658:Amoxicillin / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D001441:Bacteroides fragilis / Q000187:drug effects*; D002438:Cefoperazone / Q000494:pharmacology*; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000494:pharmacology; D004338:Drug Combinations; D010397:Penicillanic Acid / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology*; D013407:Sulbactam; D013982:Ticarcillin / Q000494:pharmacology; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000494:pharmacology*
D002969:Clavulanic Acids; D004338:Drug Combinations; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; D000667:Ampicillin; D002438:Cefoperazone; D000658:Amoxicillin; D010397:Penicillanic Acid; D001618:beta-Lactamases; D013982:Ticarcillin; D013407:Sulbactam